Phio Pharmaceuticals (PHIO) executive Bitterman bought 2,000 shares for $780 at $0.39
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Robert J Bitterman (executive at Phio Pharmaceuticals Corp., PHIO) reported that they bought 2,000 shares for $780 at $0.39 on Dec 7, 2022. After these transactions the filing shows 72,541 shares held directly.
- Reporting person
- Bitterman Robert J
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 7, 2022 | Open-market purchase (P) | Common stock, $0.0001 par value1 | +2,000 | $0.39 | $780 | 72,541 direct |
Holdings before and after
- Common stock, $0.0001 par value: 70,541 to 72,541 direct
Footnotes from the filing
- 1. Includes shares of common stock underlying unvested restricted stock units.
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Bitterman report in this PHIO Form 4?
Robert J Bitterman (executive at Phio Pharmaceuticals Corp., PHIO) reported that they bought 2,000 shares for $780 at $0.39 on Dec 7, 2022. After these transactions the filing shows 72,541 shares held directly.
How many PHIO shares does Bitterman hold after this filing?
The filing shows 72,541 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for PHIO
Earlier insider filings at PHIO
- Dec 6, 2022SEC Form 4: Bitterman Robert J bought $860 worth of shares (2,000 units at $0.43), increasing direct ownership by 3% to 70,541 units
- Dec 5, 2022SEC Form 4: Ferrara Robert L bought $2,041 worth of shares (5,000 units at $0.41), increasing direct ownership by 20% to 30,000 units
- Nov 29, 2022SEC Form 4: Bitterman Robert J bought $1,136 worth of shares (2,715 units at $0.42), increasing direct ownership by 4% to 68,541 units
- Nov 28, 2022SEC Form 4: Ferrara Robert L bought $820 worth of shares (2,000 units at $0.41), increasing direct ownership by 9% to 25,000 units
- Nov 16, 2022SEC Form 4: Bitterman Robert J bought $1,750 worth of Series D Preferred Stock (1 units at $1,750.00)
Quantisnow market dataNASDAQ
PHIO
Phio Pharmaceuticals Corp.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for PHIO
Full PHIO profile on Quantisnow Follow PHIO and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time